ICON Public (NASDAQ:ICLR) Downgraded to “Neutral” Rating by The Goldman Sachs Group
The Goldman Sachs Group lowered shares of ICON Public (NASDAQ:ICLR – Free Report) from a buy rating to a neutral rating in a research note published on Friday, MarketBeat reports. The firm currently has $200.00 price target on the medical research company’s stock, down from their previous price target of $250.00. ICLR has been the […]
The Goldman Sachs Group lowered shares of ICON Public (NASDAQ:ICLR – Free Report) from a buy rating to a neutral rating in a research note published on Friday, MarketBeat reports. The firm currently has $200.00 price target on the medical research company’s stock, down from their previous price target of $250.00. ICLR has been the […]
